BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 35614947)

  • 21. Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history.
    Bonini SA; Premoli M; Tambaro S; Kumar A; Maccarinelli G; Memo M; Mastinu A
    J Ethnopharmacol; 2018 Dec; 227():300-315. PubMed ID: 30205181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabis and Neuropsychiatric Disorders: An Updated Review.
    Chayasirisobhon S
    Acta Neurol Taiwan; 2019 Jun; 28(2)():27-39. PubMed ID: 31867704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unveiling the angiogenic effects of cannabinoids: Enhancers or inhibitors?
    Maia J; Fonseca BM; Teixeira N; Correia-da-Silva G
    Biochem Pharmacol; 2023 Sep; 215():115686. PubMed ID: 37463627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is cannabis an effective treatment for joint pain?
    Miller RJ; Miller RE
    Clin Exp Rheumatol; 2017; 35 Suppl 107(5):59-67. PubMed ID: 28967368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of the neurological benefits of phytocannabinoids.
    Maroon J; Bost J
    Surg Neurol Int; 2018; 9():91. PubMed ID: 29770251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol.
    Linciano P; Citti C; Russo F; Tolomeo F; Laganà A; Capriotti AL; Luongo L; Iannotta M; Belardo C; Maione S; Forni F; Vandelli MA; Gigli G; Cannazza G
    Sci Rep; 2020 Dec; 10(1):22019. PubMed ID: 33328530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabinoid receptor 1 binding activity and quantitative analysis of Cannabis sativa L. smoke and vapor.
    Fischedick J; Van Der Kooy F; Verpoorte R
    Chem Pharm Bull (Tokyo); 2010 Feb; 58(2):201-7. PubMed ID: 20118579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicological properties of Δ9-tetrahydrocannabinol and cannabidiol.
    Černe K
    Arh Hig Rada Toksikol; 2020 Mar; 71(1):1-11. PubMed ID: 32597140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.
    McPartland JM; Duncan M; Di Marzo V; Pertwee RG
    Br J Pharmacol; 2015 Feb; 172(3):737-53. PubMed ID: 25257544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.
    De Petrocellis L; Ligresti A; Moriello AS; Allarà M; Bisogno T; Petrosino S; Stott CG; Di Marzo V
    Br J Pharmacol; 2011 Aug; 163(7):1479-94. PubMed ID: 21175579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis.
    Dochez-Arnault J; Desdoits-Lethimonier C; Matias I; Evrard B; Lagarrigue M; Toupin M; Lardenois A; Chalmel F; Mazaud-Guittot S; Dejucq-Rainsford N; Gely-Pernot A
    BMC Med; 2023 Jul; 21(1):219. PubMed ID: 37430350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacology of Medical Cannabis.
    Amin MR; Ali DW
    Adv Exp Med Biol; 2019; 1162():151-165. PubMed ID: 31332738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Phytocannabinoids in Epilepsy Treatment: Novel Approaches and Recent Advances.
    Farrelly AM; Vlachou S; Grintzalis K
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33920188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of aldose reductase activity by Cannabis sativa chemotypes extracts with high content of cannabidiol or cannabigerol.
    Smeriglio A; Giofrè SV; Galati EM; Monforte MT; Cicero N; D'Angelo V; Grassi G; Circosta C
    Fitoterapia; 2018 Jun; 127():101-108. PubMed ID: 29427593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The endocannabinoid system.
    Kilaru A; Chapman KD
    Essays Biochem; 2020 Sep; 64(3):485-499. PubMed ID: 32648908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Pharmacological Case for Cannabigerol.
    Nachnani R; Raup-Konsavage WM; Vrana KE
    J Pharmacol Exp Ther; 2021 Feb; 376(2):204-212. PubMed ID: 33168643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Palmitoylethanolamide: A Potential Alternative to Cannabidiol.
    Clayton P; Subah S; Venkatesh R; Hill M; Bogoda N
    J Diet Suppl; 2023; 20(3):505-530. PubMed ID: 34842030
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Pellati F; Borgonetti V; Brighenti V; Biagi M; Benvenuti S; Corsi L
    Biomed Res Int; 2018; 2018():1691428. PubMed ID: 30627539
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Kopustinskiene DM; Masteikova R; Lazauskas R; Bernatoniene J
    Antioxidants (Basel); 2022 Mar; 11(4):. PubMed ID: 35453344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.